Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Enveric Biosciences(ENVB) the EBIT is -3.027 M (-20.18%);the EPS is -0.759 (+93.48%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B20.18%
----
----
EPS
-0.759493.48%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf